1. No. 349-substance use in pregnancy;Ordean;J Obstet Gynaecol Can,2017
2. World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva: World Health Organization. 2014. https://www.who.int/publications/i/item/9789241548731. [Accessed 26 July 2022].
3. Haute autorité de santé. Recommandations professionnelles: suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. 2016. https://www.has-sante.fr/jcms/c_547976/fr/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees. [Accessed 26 July 2022].
4. American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in Pregnancy. Committee Opinion No. 711. 2017. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy. [Accessed 26 July 2022].